Onyx Pharmaceuticals Inc. is set to buy Proteolix Inc. for a reported $276 million in order to gain a blood-cancer drug in its experimental stages. The Emeryville, California based company may end up paying $575 million more in future payments for development of the...
created by amyellensoden | 7 wks ago | updated 7 wks ago 54 views | 0 recommendations | 0 comments